1-20 of 20
Austin I. Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of Copanlisib and Venetoclax in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Jennifer L Crombie, Austin I Kim, Nancy L. Bartlett, Robert A. Redd, Victoria Patterson, Celeste Carey, Sobana Balasubramanian, Oreofe O. Odejide, Reid W. Merryman, Ann LaCasce, Caron A Jacobson, Eric Jacobsen, Erin M Parry, David C Fisher, Alex F. Herrera, Matthew S Davids, Margaret A. Shipp, Philippe Armand, Geoffrey P. Shouse
Journal: Blood
Blood (2023) 142 (Supplement 1): 1735.
https://doi.org/10.1182/blood-2023-181067
Published: 2023
Journal Articles

Phase I Safety and Preliminary Efficacy of Acalabrutinib, Venetoclax, and Obinutuzumab (AVO) in Patients with Relapsed/Refractory Mantle Cell Lymphoma

Austin I Kim, Philippe Armand, Robert A. Redd, Megan Forsyth, Paul Branch, Samantha Pazienza, Lisa Brennan, Victoria Patterson, Susan M Waisgerber, Reid W. Merryman, David C Fisher, Christine E. Ryan, Inhye E Ahn, Jennifer L Crombie, Oreofe O. Odejide, Ann LaCasce, Caron A Jacobson, Eric Jacobsen, Erin M Parry, Matthew S Davids, Jennifer R. Brown, Arnold S. Freedman, Peter A. Riedell, Mark Alan Murakami
Journal: Blood
Blood (2023) 142 (Supplement 1): 3031.
https://doi.org/10.1182/blood-2023-173103
Published: 2023
Journal Articles

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

Clinical Trials & Observations
Mwanasha H. Merrill, Parastoo B. Dahi, Robert A. Redd, Mikaela M. McDonough, Yi-Bin Chen, Zachariah DeFilipp, Alex F. Herrera, David C. Fisher, Ann S. LaCasce, Oreofe O. Odejide, Samuel Y. Ng, Caron A. Jacobson, Reid W. Merryman, Austin I. Kim, Yago L. Nieto, Craig S. Sauter, Gunjan L. Shah, Jasmine M. Zain, Philippe Armand, Eric D. Jacobsen
Journal: Blood
Blood (2023) 142 (7): 621–628.
https://doi.org/10.1182/blood.2023020244
Published: 2023
Journal Articles

A Pilot Study of Axicabtagene Ciloleucel (axi-cel) for the Treatment of Relapsed/Refractory Primary and Secondary Central Nervous System Lymphoma (CNSL)

Caron A. Jacobson, Caroline Falvey, Riemke Bouvier, Sarah Hogan, Elizabeth Kendricken, Julia Jones, Elizabeth Grimm, Robert A. Redd, Eudocia Q Lee, Luis Gonzalez Castro, Ugonma Chukwueke, Jose McFaline Figueroa, Austin I. Kim, Alexandra Torres, Linda Ramsdell, Leslie S. Kean, Ulrike Gerdemann, Alexandre Albanese, Paula Keskula, David Meredith, Lynette Sholl, Soumya Poddar, Madison Davis, Daquin Mao, Simone Filosto, Mike Mattie, Philippe Armand, Lakshmi Nayak
Journal: Blood
Blood (2022) 140 (Supplement 1): 1060–1061.
https://doi.org/10.1182/blood-2022-165256
Published: 2022
Journal Articles

Updated Results from a Phase I/II Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Richter's Syndrome (RS)

Christine E. Ryan, Jennifer L. Crombie, Svitlana Tyekucheva, Mikaela M. McDonough, Josie S. Montegaard, Austin I. Kim, Jacob D. Soumerai, Alvaro J. Alencar, Shruti Bhandari, David C. Fisher, Jennifer R. Brown, Matthew S. Davids
Journal: Blood
Blood (2022) 140 (Supplement 1): 9871–9872.
https://doi.org/10.1182/blood-2022-169986
Published: 2022
Journal Articles

A Phase 2 Study of Pembrolizumab (MK-3475) after Autologous Stem Cell Transplantation in Patients with T-Cell Non-Hodgkin Lymphoma

Mwanasha H. Merrill, Parastoo B. Dahi, Robert A. Redd, Mikaela M. McDonough, Yi-Bin Chen, Ann S. LaCasce, David C. Fisher, Alex F. Herrera, Caron A. Jacobson, Austin I. Kim, Reid W Merryman, Oreofe O. Odejide, Samuel Ng, Yago Nieto, Craig S. Sauter, Gunjan L. Shah, Jasmine Zain, Philippe Armand, Eric D Jacobsen
Journal: Blood
Blood (2022) 140 (Supplement 1): 1185–1187.
https://doi.org/10.1182/blood-2022-164839
Published: 2022
Journal Articles

Dual Immune Checkpoint Agents in Combination with Rituximab for Patients with Relapsed or Refractory Follicular Lymphoma

Reid W Merryman, Robert A. Redd, Arnold S. Freedman, Inhye E. Ahn, Jennifer R. Brown, Jennifer L. Crombie, Matthew S. Davids, David C. Fisher, Eric D Jacobsen, Austin I. Kim, Ann S. LaCasce, Samuel Ng, Oreofe O. Odejide, Erin Michelle Parry, Iris Isufi, Justin Kline, Jonathon B. Cohen, Neha Mehta-Shah, Nancy L. Bartlett, Matthew Mei, Philippe Armand, Caron A. Jacobson
Journal: Blood
Blood (2022) 140 (Supplement 1): 6531–6533.
https://doi.org/10.1182/blood-2022-159823
Published: 2022
Journal Articles

Updated Results from a Multicenter, Phase 2 Study of Acalabrutinib, Venetoclax, Obinutuzumab (AVO) in a Population of Previously Untreated Patients with CLL Enriched for High-Risk Disease

Christine E. Ryan, Benjamin L. Lampson, Svitlana Tyekucheva, Liam R. Hackett, Yue Ren, Samantha J. Shupe, Stacey M. Fernandes, Jennifer L. Crombie, Samuel Ng, Austin I. Kim, Inhye E. Ahn, Matthew J Weinstock, Samantha Pazienza, Josie S. Montegaard, Victoria Patterson, Caron A. Jacobson, Ann S. LaCasce, Philippe Armand, David C. Fisher, Jon E. Arnason, Steve Lo, Adam Olszewski, Jennifer R. Brown, Matthew S. Davids
Journal: Blood
Blood (2022) 140 (Supplement 1): 837–838.
https://doi.org/10.1182/blood-2022-168003
Published: 2022
Journal Articles

Prognostic Value of Minimal Residual Disease (MRD) Among Patients with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

Eleanor Taranto, Robert A. Redd, Erin Jeter, Kristin M McHugh, Jennifer R Brown, Jennifer L. Crombie, Matthew S. Davids, David C. Fisher, Arnold S. Freedman, Eric D Jacobsen, Caron Jacobson, Austin I. Kim, Ann S. LaCasce, Benjamin L. Lampson, Samuel Y. Ng, Oreofe O. Odejide, Erin Michelle Parry, Parastoo B. Dahi, Yago Nieto, Robin M. Joyce, Yi-Bin Chen, Alex F. Herrera, Philippe Armand, Reid W Merryman
Journal: Blood
Blood (2021) 138 (Supplement 1): 3491.
https://doi.org/10.1182/blood-2021-147263
Published: 2021
Journal Articles

A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy

Yun Choi, Jessica Caro, Xiaochun Li, Arshed Al-Obeidi, Sharyn Lynn Kurtz, Austin I. Kim, Julie E. Chang, Adam J. Olszewski, Adam Zayac, Andrew Matthews, Stefan K. Barta, Suchitra Sundaram, Francisco J. Hernandez-Ilizaliturri, Lori A. Leslie, Paolo Caimi, Jordan Carter, Kevin A. David, Andrew M. Evens, Myung Sun Kim, Sarah J. Nagle, Judith Goldberg, Catherine S. Diefenbach
Journal: Blood
Blood (2021) 138 (Supplement 1): 184.
https://doi.org/10.1182/blood-2021-146398
Published: 2021
Journal Articles

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

Gabriel K. Griffin, Jason L. Weirather, Margaretha G. M. Roemer, Mikel Lipschitz, Alyssa Kelley, Pei-Hsuan Chen, Daniel Gusenleitner, Erin Jeter, Christine Pak, Evisa Gjini, Bjoern Chapuy, Michael H. Rosenthal, Jie Xu, Benjamin J. Chen, Aliyah R. Sohani, Scott B. Lovitch, Jeremy S. Abramson, Jeffrey J. Ishizuka, Austin I. Kim, Caron A. Jacobson, Ann S. LaCasce, Christopher D. Fletcher, Donna Neuberg, Gordon J. Freeman, F. Stephen Hodi, Kyle Wright, Azra H. Ligon, Eric D. Jacobsen, Philippe Armand, Margaret A. Shipp, Scott J. Rodig
Journal: Blood
Blood (2021) 137 (10): 1353–1364.
https://doi.org/10.1182/blood.2020006464
Published: 2021
Includes: Supplemental data
Journal Articles

Prognostic Value of Circulating Tumor DNA (ctDNA) in Autologous Stem Cell Graft and Post-Transplant Plasma Samples Among Patients with Diffuse Large B-Cell Lymphoma

Reid W Merryman, MD, Robert A. Redd, MS, Eleanor Taranto, MD, Gulrayz Ahmed, MD, Erin Jeter, Kristin M McHugh, Jennifer R. Brown, MD PhD, Jennifer Crombie, MD, Matthew S. Davids, MD, David C. Fisher, MD, Arnold S. Freedman, MD, Eric Jacobsen, MD, Caron Jacobson, MD MMSc, Austin I. Kim, MD, Ann S. LaCasce, MD MSc, Benjamin L. Lampson, MD PhD, Samuel Ng, MD PhD, Oreofe O. Odejide, MDMPH, Parastoo B. Dahi, MD, Yago Nieto, MD, Robin M. Joyce, MD, Yi-Bin Chen, MD, Alex F. Herrera, MD, Philippe Armand, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-140965
Published: 2020
Journal Articles

Updated Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab (AVO) for Frontline Treatment of Chronic Lymphocytic Leukemia (CLL)

Matthew S. Davids, MD, Benjamin L. Lampson, MD PhD, Svitlana Tyekucheva, PhD, Jennifer L. Crombie, MD, Samuel Ng, MD PhD, Austin I. Kim, MD, Matthew Weinstock, MD, Jessica Lowney, Samantha Pazienza, Josie Montegaard, NP, Victoria Patterson, BSN, RN, Caron A. Jacobson, MD, Ann S. LaCasce, MD MSc, Philippe Armand, MD PhD, Jon E. Arnason, MD, David C. Fisher, MD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-139864
Published: 2020
Journal Articles

Interim Positron Emission Tomography (iPET) Assessed Using Deauville Score for Patients with Follicular Lymphoma Receiving First-Line Chemoimmunotherapy

Reid W Merryman, MD, Gabriela Spilberg, MD, Patrizia Mondello, MDPhDMSc, Robert A. Redd, MS, Eleanor Taranto, MD, Gulrayz Ahmed, MD, Erin Jeter, Matthew Chase, MD, Gilles Salles, MDPhD, Andrew D Zelenetz, MD PhD, Jennifer R Brown, MD PhD, Jennifer Crombie, MD, Matthew S. Davids, MD, David C. Fisher, MD, Arnold S. Freedman, MD, Eric D Jacobsen, MD, Caron A. Jacobson, MD, Austin I. Kim, MD, Ann S. LaCasce, MD MSc, Benjamin L. Lampson, MD PhD, Samuel Y. Ng, MDPhD, Oreofe Odejide, MD, Philippe Armand, MD PhD, Heather A. Jacene, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-135919
Published: 2020
Journal Articles

Updated Results from a Phase I/II Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL/SLL or Richter's Syndrome

Jennifer L. Crombie, MD, Svitlana Tyekucheva, PhD, Zixu Wang, MS, Alexandra Savell, BS, Lisa Brennan, RN, BSN, Jessica Lowney, Karen Francoeur, RN, Josie Montegaard, NP, Austin I. Kim, MD, Jacob D. Soumerai, MD, Jon E. Arnason, MD, Allan Louie Cruz, MD, Sigrid Berg, MD, David C. Fisher, MD, Jennifer R Brown, MD PhD, Matthew S. Davids, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-138811
Published: 2020
Journal Articles

Preliminary Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Benjamin L. Lampson, MD PhD, Svitlana Tyekucheva, PhD, Jennifer L. Crombie, MD, Austin I Kim, MD, Reid W Merryman, MD, Jessica Lowney, Josie Montegaard, NP, Victoria Patterson, RN, Caron A. Jacobson, MD, Eric D Jacobsen, MD, Ann S. LaCasce, MD MMSc, Jon E. Arnason, MD, Philippe Armand, MD PhD, David C. Fisher, MD, Jennifer R. Brown, MD PhD, Matthew S. Davids, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 32.
https://doi.org/10.1182/blood-2019-127506
Published: 2019
Journal Articles

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

Clinical Trials & Observations
Philippe Armand, Yi-Bin Chen, Robert A. Redd, Robin M. Joyce, Jad Bsat, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman, Parastoo B. Dahi, Yago Nieto, Ann S. LaCasce, David C. Fisher, Samuel Y. Ng, Oreofe O. Odejide, Arnold S. Freedman, Austin I. Kim, Jennifer L. Crombie, Caron A. Jacobson, Eric D. Jacobsen, Jeffrey L. Wong, Sanjay S. Patel, Jerome Ritz, Scott J. Rodig, Margaret A. Shipp, Alex F. Herrera
Journal: Blood
Blood (2019) 134 (1): 22–29.
https://doi.org/10.1182/blood.2019000215
Published: 2019
Journal Articles

Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Phase 2 Clinical Trials and Off-Trial Experience

Reid W Merryman, MD, Brad S Kahl, MD, Robert A. Redd, MS, Jad Bsat, BA, Matthew Lewis Chase, Ann S. LaCasce, MD MSc, Arnold S. Freedman, MD, Caron A. Jacobson, MD, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Jennifer L Crombie, MD, Austin I Kim, MD, Oreofe O. Odejide, MD, Matthew S. Davids, MD, Jennifer R. Brown, MD PhD, Heather A. Jacene, Mehta-Shah Neha, Natasha Edwin, MD, Amanda F Cashen, MD, Nancy L. Bartlett, MD, Armin Ghobadi, MD, Philippe Armand, MD PhD, Robin M. Joyce, MD, Eric D Jacobsen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 145.
https://doi.org/10.1182/blood-2018-99-110520
Published: 2018
Journal Articles

PD-1 Blockade for Diffuse Large B-Cell Lymphoma after Autologous Stem Cell Transplantation

Yi-Bin Chen, MD, Philippe Armand, MD PhD, Robert A. Redd, MS, Jad Bsat, BA, Reid W Merryman, MD, Kimberly Coleman, RN, Alex F. Herrera, MD, Parastoo B. Dahi, MD, Yago Nieto, MD PhD, Ann S. LaCasce, MD MSc, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Oreofe O. Odejide, MD, Arnold S. Freedman, MD, Austin I Kim, MD, Jennifer L Crombie, MD, Caron A. Jacobson, MD, Eric D Jacobsen, MD, Jeffrey L Wong, MD PhD, Sanjay S Patel, MD MSc, MPH, Jerome Ritz, MD PhD, Scott J Rodig, MDPhD, Margaret A. Shipp, MD, Robin M. Joyce, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 706.
https://doi.org/10.1182/blood-2018-99-114914
Published: 2018
Journal Articles

PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation

Philippe Armand, MD PhD, Yi-Bin Chen, MD, Robert A. Redd, MS, Robin M. Joyce, MD, Jad Bsat, BA, Reid W Merryman, MD, Kimberly Coleman, RN, Parastoo B. Dahi, MD, Yago Nieto, MD PhD, Ann S. LaCasce, MD MSc, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Oreofe O. Odejide, MD, Arnold S. Freedman, MD, Austin I Kim, MD, Jennifer L Crombie, MD, Caron A. Jacobson, MD, Eric D Jacobsen, MD, Jeffrey L Wong, MD PhD, Mikel Lipschitz, M.S., Sanjay S Patel, MD MSc, MPH, Jerome Ritz, MD PhD, Scott J Rodig, MDPhD, Margaret A. Shipp, MD, Alex F Herrera, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1650.
https://doi.org/10.1182/blood-2018-99-113685
Published: 2018